These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36897102)

  • 21. MicroRNA expression profiling of RAS-mutant thyroid tumors with follicular architecture: microRNA signatures to discriminate benign from malignant lesions.
    Macerola E; Poma AM; Vignali P; Proietti A; Torregrossa L; Ugolini C; Basolo A; Matrone A; Elisei R; Santini F; Basolo F
    J Endocrinol Invest; 2023 Aug; 46(8):1651-1662. PubMed ID: 36749451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The frequency of malignant disease in cytological group of suspected cancer (ultrasound-guided fine-needle aspiration biopsy of nonpalpable thyroid nodules)].
    Miseikyte-Kaubriene E; Ulys A; Trakymas M
    Medicina (Kaunas); 2008; 44(3):189-94. PubMed ID: 18413985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression Levels of miR-30a-5p in Papillary Thyroid Carcinoma: A Comparison Between Serum and Fine Needle Aspiration Biopsy Samples.
    Igci YZ; Ozkaya M; Korkmaz H; Bozgeyik E; Bayraktar R; Ulasli M; Erkilic S; Eraydin A; Oztuzcu S
    Genet Test Mol Biomarkers; 2015 Aug; 19(8):418-23. PubMed ID: 26047355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic accuracy of fine needle aspiration biopsy for detection of malignancy in pediatric thyroid nodules: protocol for a systematic review and meta-analysis.
    Lai SW; Roberts DJ; Rabi DM; Winston KY
    Syst Rev; 2015 Sep; 4():120. PubMed ID: 26399232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer.
    Vriens MR; Weng J; Suh I; Huynh N; Guerrero MA; Shen WT; Duh QY; Clark OH; Kebebew E
    Cancer; 2012 Jul; 118(13):3426-32. PubMed ID: 22006248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA expression profile helps to distinguish benign nodules from papillary thyroid carcinomas starting from cells of fine-needle aspiration.
    Agretti P; Ferrarini E; Rago T; Candelieri A; De Marco G; Dimida A; Niccolai F; Molinaro A; Di Coscio G; Pinchera A; Vitti P; Tonacchera M
    Eur J Endocrinol; 2012 Sep; 167(3):393-400. PubMed ID: 22728346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A panel of four miRNAs accurately differentiates malignant from benign indeterminate thyroid lesions on fine needle aspiration.
    Keutgen XM; Filicori F; Crowley MJ; Wang Y; Scognamiglio T; Hoda R; Buitrago D; Cooper D; Zeiger MA; Zarnegar R; Elemento O; Fahey TJ
    Clin Cancer Res; 2012 Apr; 18(7):2032-8. PubMed ID: 22351693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.
    Bongiovanni M; Molinari F; Eszlinger M; Paschke R; Barizzi J; Merlo E; Giovanella L; Fasolini F; Cattaneo F; Ramelli F; Mazzucchelli L; Frattini M
    Cytopathology; 2015 Oct; 26(5):288-96. PubMed ID: 25487739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ADM3, TFF3 and LGALS3 are discriminative molecular markers in fine-needle aspiration biopsies of benign and malignant thyroid tumours.
    Karger S; Krause K; Gutknecht M; Schierle K; Graf D; Steinert F; Dralle H; Führer D
    Br J Cancer; 2012 Jan; 106(3):562-8. PubMed ID: 22223087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ThyroSeq v3 for Bethesda III and IV: An institutional experience.
    Desai D; Lepe M; Baloch ZW; Mandel SJ
    Cancer Cytopathol; 2021 Feb; 129(2):164-170. PubMed ID: 33030808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of repeat cytology with reflex ThyroSeq genomic classifier for indeterminant thyroid cytology.
    O'Conor CJ; Dash RC; Jones CK; Jiang XS
    Cancer Cytopathol; 2022 Jun; 130(6):469-476. PubMed ID: 35045202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Next-Generation Sequencing Identifies a Highly Accurate miRNA Panel That Distinguishes Well-Differentiated Thyroid Cancer from Benign Thyroid Nodules.
    Mazeh H; Deutch T; Karas A; Bogardus KA; Mizrahi I; Gur-Wahnon D; Ben-Dov IZ
    Cancer Epidemiol Biomarkers Prev; 2018 Aug; 27(8):858-863. PubMed ID: 30049841
    [No Abstract]   [Full Text] [Related]  

  • 34. Molecular Testing for miRNA, mRNA, and DNA on Fine-Needle Aspiration Improves the Preoperative Diagnosis of Thyroid Nodules With Indeterminate Cytology.
    Labourier E; Shifrin A; Busseniers AE; Lupo MA; Manganelli ML; Andruss B; Wylie D; Beaudenon-Huibregtse S
    J Clin Endocrinol Metab; 2015 Jul; 100(7):2743-50. PubMed ID: 25965083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a microRNA-based molecular assay for the detection of papillary thyroid carcinoma in aspiration biopsy samples.
    Mazeh H; Mizrahi I; Halle D; Ilyayev N; Stojadinovic A; Trink B; Mitrani-Rosenbaum S; Roistacher M; Ariel I; Eid A; Freund HR; Nissan A
    Thyroid; 2011 Feb; 21(2):111-8. PubMed ID: 21275764
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An independent study of a gene expression classifier (Afirma) in the evaluation of cytologically indeterminate thyroid nodules.
    McIver B; Castro MR; Morris JC; Bernet V; Smallridge R; Henry M; Kosok L; Reddi H
    J Clin Endocrinol Metab; 2014 Nov; 99(11):4069-77. PubMed ID: 24780044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA signature in thyroid fine needle aspiration cytology applied to "atypia of undetermined significance" cases.
    Shen R; Liyanarachchi S; Li W; Wakely PE; Saji M; Huang J; Nagy R; Farrell T; Ringel MD; de la Chapelle A; Kloos RT; He H
    Thyroid; 2012 Jan; 22(1):9-16. PubMed ID: 22136206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignancy risk assessment in adenomatoid nodules and suspicious follicular lesions of the thyroid obtained by fine needle aspiration cytology.
    Dabelić N; Matesa N; Matesa-Anić D; Kusić Z
    Coll Antropol; 2010 Jun; 34(2):349-54. PubMed ID: 20698101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of thyroid fine needle aspiration biopsy results before and after implementation of Bethesda classification.
    Ozdemir D; Bestepe N; Faki S; Kilicarslan A; Parlak O; Ersoy R; Cakir B
    Cytopathology; 2017 Oct; 28(5):400-406. PubMed ID: 28727204
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A core needle biopsy provides more malignancy-specific results than fine-needle aspiration biopsy in thyroid nodules suspicious for malignancy.
    Hakala T; Kholová I; Sand J; Saaristo R; Kellokumpu-Lehtinen P
    J Clin Pathol; 2013 Dec; 66(12):1046-50. PubMed ID: 23863219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.